Organization
Biocon Ltd.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Biocon Ltd.
... Biocon's partner Mylan has resubmitted the Marketing Authorization Applications (MAAs) for our proposed ...
... (rDNA) Technology market are F. Hoffmann-La Roche Ltd, Monsanto Company, Amgen Inc, Biocon, Biogen, Eli Lilly and Company, GenScript, GlaxoSmithKline plc, Horizon Discovery Group PLC, ...
... model of lung transplantation. The asset is being developed in collaboration with Biocon, Asia's leading biopharmaceutical company. The pre-clinical efficacy proof-of-concept and pharmacodynamic studies were ...
... Tonghua Dongbao Pharmaceutical Co. Chapter 6 profiles leading companies in India: · Biocon · Dr. Reddy's Laboratories · Intas Biopharmaceuticals · Ranbaxy (Sun Pharma) · ...
... global diabetes injection pens market are AstraZeneca plc, Becton, Dickinson and Company, Biocon Ltd., Eli Lilly and Company, Jiangsu Delfu Co., Novo Nordisk A/S, Owen ...
... the erythropoietin market: - Amgen - Johnson & Johnson - Roche - Biocon - 3SBio - Pfizer - Kyowa Hakko Kirin Co Ltd - LG ...
... Mylan and Biocon, which have had trouble getting to the regulatory finish line in Europe ...
... delivered by renowned faculty from KGI, along with experiential learning sessions at Biocon through subject matter experts. Named among Time magazine's 100 most influential people ...
... Ltd., Abnova Corporation, Celltrion, Inc., InvivoGen, Bio-Techne by Novus Biologicals, LLC, and Biocon Ltd. as some of the prominent companies currently operating in the global ...
... Global Biosimilar Insulin Market Report 2022: Key Players are Biocon, Biogenomics, Eli Lilly, Geropharm, Julphar Gulf Pharmaceutical Industries, Samsung Bioepis, Sedico & ...
... Abdi Ibrahim has announced collaboration with Biocon, to launch the first biosimilar product in Algeria, an insulin market worth ...
... 2027" - Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2027. Biocon Ltd. (India), Tonghua Dongbao Pharmaceuticals Co., Ltd. (China), Adocia (France.), Merck & ...
... Amgen, Inc., Bayer AG, Merck & Co., Inc., Dr. Reddy's Laboratories Ltd., Biocon Ltd., Eli Lilly and Company, Sanofi, Fresenius Kabi, GlaxoSmithKline plc, Johnson & ...
... Mylan N.V. (NASDAQ, TASE: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) today announced that the U.S. Food ...
... Bio Sci LLC, Axxam SpA, Bio-Cancer Treatment International Ltd, BioApex sro, Biocad, Biocon Ltd, Biogen Inc, BioHealthonomics Inc, Biomar Microbial Technologies, Bionovis SA, Bionure Farma ...
... pen market such as Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford, Ypsomed, Biocon Ltd. The major market players are evaluated on various parameters such as ...
... Asia Pacific are involved in the development of new biosimilars. For example, Biocon's subsidiary Syngene International entered into an agreement with Bristol-Myers Squibb to extend ...
... Mylan N.V. (NASDAQ, TASE: MYL) and Biocon Ltd. (BSE code: 532523, NSE: BIOCON) today announced the presentation of new ...
... Pharmaceuticals Plc, Bayer AG, Beta-Cell NV, Betagenon AB, Betta Pharmaceuticals Co Ltd, Biocon Ltd, BioLingus AG, BioRestorative Therapies Inc, Biozeus, Biscayne Pharmaceuticals Inc, Boehringer Ingelheim ...
... Key companies operating in this pipeline space include Bolder Biotechnology, USV, Apotex, Biocon, Biogenomics, Generon and Pfizer. Chemotherapy-induced anemia is a very common side effect ...
... Limited - Kyowa Hakko Kirin Co Ltd - Pfizer - 3SBio - Biocon - Roche - Johnson & Johnson - Amgen Visiongain's study is intended ...
... plc (Ireland), Animas Corporation (U.S.), Tandem Diabetes Care, Inc. (U.S.), Sanofi (France), Biocon Ltd. (India), Eli Lilly and Company (U.S.), and Insulet Corporation (U.S.). Intl: ...
... Pharmaceuticals Co Ltd, BeyondSpring Pharmaceuticals Inc, Bio-Path Holdings Inc, Biocad, BioCancell Ltd, Biocon Ltd, BioLineRx Ltd, Bionovis SA, Biothera Pharmaceutical Inc, Blueprint Medicines Corp, Boehringer ...
... Nordisk A/S F. Hoffmann-La Roche, Ltd. Abbott Laboratories Wockhardt Ltd. Ypsomed AG Biocon Ltd. Eli Lilly and Company Key Topics Covered: 1. Research Methodology 2. ...
... pens market are Novo Nordisk A/S, Eli Lilly and Company, AstraZaneca plc., Biocon Ltd., and Sanofi S.A. Transparency Market Research reports that the competitive landscape ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤